Drug Stocks March 2026: Top 3 Picks for Growth and Safety
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
Market volatility is back in March 2026, and defensive moves can help. This guide highlights three defensive ETFs wor...
As AI workloads demand more network performance, Arista Networks and Broadcom stand out. This guide breaks down their...
Geopolitical tensions surrounding Iran are rattling markets. In this environment, SPLG stands out as a low-cost ancho...
U.S. authorities charged the co-founder of Super Micro Computer and two associates in a $2.5 billion scheme to ship s...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
The SEC is exploring a proposal that could let U.S. public companies report semiannually instead of quarterly, prompt...
A sharp look at how perfectly rational branding decisions can erode meaning. Intel and Toyota illustrate why investor...
When a high-profile TV season is shelved, the ripple effects go beyond the screen. This article breaks down the finan...
Executives gathered at the Fortune CEO Initiative dinner to debate debt risks, global diplomacy, and the role of busi...